The Filing Desk

Acacia Research

ACTG · Nasdaq · Financials · Financials, fiscal 2016 to 2025

ACTG · Last close · November 19, 2026
$4.08
Value Acacia Research yourself

Acacia Research's revenue rose 133.2% to $285 million in fiscal 2025. Its operating margin was 2.2%, up from −26.9% a year earlier. The diluted share count fell 2.1%.

ACACIA RESEARCH CORP Latest fiscal year ended December 31, 2025 10-K filed March 12, 2026 · 0000934549-26-000010 Updated
Revenue
$285M
133.2%
Operating margin
2.2%
29.2 pts
Net income
$22M
 
Free cash flow
—
 
Return on equity
4.1%
10.8 pts
Market cap
$398M
Nov 19 close
P/E
—
Loss: no P/E

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

About these figures. Free cash flow margin for fiscal 2025 is blank: the 10-K's structured data doesn't include every figure it needs.

Charts show fiscal years, from the 10-K filings.

What Acacia Research does

Acacia Research buys and runs businesses in public and private markets, including in the industrial, energy and technology sectors. It looks for businesses that can generate strong free cash flow, and it says it acts as an owner and operator rather than only a financial investor. Its largest shareholder, Starboard Value, helps it find and assess acquisitions.

It has two main operations. The first invests in intellectual property: it licenses and enforces patent portfolios, either buying the patents outright or obtaining the rights to them. The second is its energy business, Benchmark Energy II, an independent oil and natural gas company in Austin, Texas that acquires, produces and develops oil and gas properties in Texas and Oklahoma. Acacia holds 73.5% of Benchmark.

Revenue therefore comes from patent licensing and settlements and from selling oil and gas, along with whatever its other acquired operating businesses earn.

Its biggest risks, as it describes them

  • Disappointing results from patent litigation, which is hard to predict and can invalidate its patents.
  • Swings in oil, natural gas and natural gas liquids prices, which could force write-downs at Benchmark.
  • Reliance on its largest shareholder, Starboard, which controls most of the voting power and helps source deals.
  • A history of losses, and the chance that acquired businesses do not perform as hoped.
  • A material weakness in internal control over financial reporting at Benchmark.
From Acacia Research's annual report on Form 10-K, filed March 12, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2017 to 2025, earnings per share fell 8.3% a year and net income 0.3% a year, as new shares raised the share count by 92% and diluted each share's earnings.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments708386440—307
Debt incl. finance leases————93
Net debt (negative means net cash)————−214
Net debt to EBITDA————−4.3x
Debt to equity————0.2x
Interest coverage1.8x−6.2x10.2x−5.1x0.7x
Current ratio3.6x4.9x20.1x8.5x9.2x
Quick ratio3.6x4.7x19.7x7.9x8.6x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Acacia Research's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

Insider trades

Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought Acacia Research shares on the open market, and 2 insiders sold $457,560.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Sep 15, 2026Isaac T. KohlbergDirectorSold24,000$4.55$109,200Form 4
Sep 3, 2026Maureen OconnellDirectorSold12,466$4.57$56,970Form 4
Sep 2, 2026Maureen OconnellDirectorSold20,534$4.63$95,072Form 4
Aug 19, 2026Maureen OconnellDirectorSold10,000$4.60$46,000Form 4
Aug 12, 2026Isaac T. KohlbergDirectorSold32,188$4.67$150,318Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score———
Rule of 4093.1%−82.8%—
Altman Z''18.534.585.67
Accruals ratio16.0%−12.4%−7.0%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassFailPass
Cash from operations is positiveFailPassPass
Return on assets rosePassFailPass
Cash from operations exceeds net incomeFailPassPass
Debt fell relative to assets———
Current ratio rosePassFailPass
Share count didn't riseFailFailPass
Gross margin rosePassFailPass
Revenue rose relative to assetsPassFailPass
F-score———
Companies that report no gross profit are scored on the other eight.

Compare

Put Acacia Research side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
Acacia ResearchFY25133.2%2.2%——−4.3x—
CannaeFY25−6.4%−28.2%−6.7%−6.9%—5Compare
KingswayFY2523.4%−1.8%—−2.7%9.1x—Compare
Compass DiversifiedFY254.8%0.6%−2.7%0.4%11.8x5Compare
JefferiesFY254.4%—−23.2%26.1%0.8x—Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue—6513211301259125122285
Revenue growth——101.1%−91.5%164.8%−59.7%393.4%111.2%−2.2%133.2%
Gross profit——22−755222723084
Research and development————0011——
Operating income−37−27−25−23−2014−4021−336
Net income−5422−105−17109149−12567−3622
Diluted EPS (US$)−1.080.44−2.10−0.401.481.91−3.130.58−0.360.22
Diluted shares (millions)50515051579842929997
Cash flow
Cash from operations341321−2−2013−37−225075
Capital expenditure00000010149—
Free cash flow341321−2−2013−38−23−99—
Dividends paid0000123100
Share buybacks005044510200
Acquisitions000003309881
Stock-based compensation99−01224356
Balance sheet at fiscal year end
Cash and short-term investments158137166169166708386440—307
Debt incl. finance leases—————————93
Total assets296309224218511799483634756771
Total liabilities2913333521235419444204187
Shareholders' equity266294189173277419258568515543
Margins and ratios
Gross margin——16.9%−62.6%16.6%432.8%36.9%57.8%24.2%29.6%
Operating margin—−41.7%−18.8%−208.2%−65.5%121.2%−67.7%16.7%−26.9%2.2%
Net margin—33.9%−79.9%−152.2%366.8%1,242.9%−211.2%53.6%−29.5%7.6%
Free cash flow margin—19.8%15.8%−22.1%−66.5%110.2%−64.3%−18.1%−80.6%—
Rule of 40 (growth + FCF margin)——116.9%−113.6%98.3%50.6%329.1%93.1%−82.8%—
Return on capital——————————
Return on equity−18.8%7.9%−43.4%−9.4%48.5%42.8%−36.9%16.2%−6.7%4.1%
Return on assets−16.8%7.3%−39.4%−7.7%29.9%22.8%−19.5%12.0%−5.2%2.8%
Net debt to EBITDA—————————−4.3x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Acacia Research's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Acacia Research.